New Age Alpha Advisors LLC Purchases Shares of 18,119 Select Medical Holdings Co. (NYSE:SEM)

New Age Alpha Advisors LLC acquired a new position in Select Medical Holdings Co. (NYSE:SEM) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 18,119 shares of the health services provider’s stock, valued at approximately $342,000.

Other institutional investors also recently modified their holdings of the company. Quarry LP bought a new position in shares of Select Medical during the 3rd quarter worth approximately $30,000. Smartleaf Asset Management LLC grew its stake in shares of Select Medical by 179.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider’s stock worth $43,000 after acquiring an additional 1,473 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new stake in Select Medical in the 3rd quarter worth about $81,000. Cibc World Markets Corp bought a new position in shares of Select Medical in the fourth quarter valued at approximately $191,000. Finally, Vista Finance LLC purchased a new stake in shares of Select Medical during the 4th quarter valued at $193,000. 89.48% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on SEM shares. StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, February 21st. UBS Group decreased their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Benchmark upgraded Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price objective on the stock in a research report on Monday, February 24th. Finally, Royal Bank of Canada dropped their target price on shares of Select Medical from $47.00 to $23.00 and set an “outperform” rating for the company in a research report on Monday, February 24th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, Select Medical has an average rating of “Moderate Buy” and a consensus price target of $27.25.

Select Medical Price Performance

Shares of NYSE:SEM opened at $16.52 on Wednesday. The company’s fifty day moving average is $18.28 and its 200 day moving average is $24.70. Select Medical Holdings Co. has a 52 week low of $15.97 and a 52 week high of $40.98. The stock has a market cap of $2.13 billion, a PE ratio of 10.01, a PEG ratio of 0.64 and a beta of 1.56. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.29 by ($0.11). The firm had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. Research analysts anticipate that Select Medical Holdings Co. will post 1.17 earnings per share for the current year.

Select Medical Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 13th. Investors of record on Monday, March 3rd were issued a dividend of $0.0625 per share. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.51%. Select Medical’s dividend payout ratio is presently 15.15%.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.